跳至主要内容
临床试验/NCT07668687
NCT07668687招募中不适用

European Multi-Centre Castor™ and Cratos™ Branched Endovascular Arch Repair Registry

Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd4 个研究点 分布在 2 个国家目标入组 100 人开始时间: 2025年9月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
4

研究概览

简要总结

The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.

详细描述

The CEDAR registry is a post-market clinical study with retrospective and prospective enrollment and retrospective and prospective data collection.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Implantation of a Castor™ or Cratos™ single branch endoprothesis with incorporation of the left subclavian artery
  • Age >18 years

排除标准

  • Patients allergic to the materials of the device;
  • Patients with severe or potentially systemic infections that increase the chance of graft infection;
  • Minors and pregnant women;
  • Branch for other supra-aortic vessels than the LSA
  • Rejection of participation.

研究者

发起方
Shanghai MicroPort Endovascular MedTech(Group)Co., Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

European Multi-Centre Post-Market Registry on... | 临床试验